Deficiency in Virion Secretion and Decreased Stability of the Hepatitis B Virus Immune Escape Mutant G145R

Hepatology

Volumn 38, Issue 5, 2003, Pages 1274-1281

  Kalinina, Tatyana ^a,b   Iwanski, Alicja ^a   Will, Hans ^a   Sterneck, Martina ^a,c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN; MEMBRANE PROTEIN; MESSENGER RNA; VITRONECTIN; WT1 PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; G145R GENE; GENE; GENETIC STABILITY; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATITIS B VIRUS IMMUNE ESCAPE MUTANT; IN VITRO STUDY; LIVER TRANSPLANTATION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; RECIPIENT; VACCINATION; VIRION; VIRUS IMMUNITY; VIRUS MUTANT; VIRUS PARTICLE;

EID: 0142151744     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50484     Document Type: Article

References (32)

1. Bartholomeusz A, Locarnini S. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. HEPATOLOGY 2001;34:432-435.
2. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997;4(Suppl 1):11-20.
3. Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. HEPATOLOGY 2000;31:1037-1044.
4. Wallace LA, Carman WF. Surface gene variation of HBV: scientific and medical relevance. Viral Hepatol Rev 1997;3:5-16.
5. Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 1994;169:1374-1376.
6. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. HEPATOLOGY 1997;26:786-791.
7. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. HEPATOLOGY 1999;30:1312-1317.
8. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. HEPATOLOGY 1996;24:489-493.
9. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis [see comments]. HEPATOLOGY 1998;27:213-222.
10. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation [see comments]. HEPATOLOGY 1998;27:254-263.
11. Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999;52:25-137.
12. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
13. Purcell RH. Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A 1994;91:2401-2406.
14. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-908.
15. Hawkins AE, Gilson RJ, Gilbert N, Wreghitt TG, Gray JJ, Ahlers-de Boer I, Tedder RS, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996;24:8-14.
16. Cooreman MP, van Roosmalen MH, te Morsche R, Sunnen CM, de Ven EM, Jansen JB, Tytgat GN, et al. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring loop escape mutations. HEPATOLOGY 1999;30:1287-1292.
17. Francois G, Kew M, Van Damme P, Mphahlele MJ, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine 2001;19:3799-3815.
18. Kalinina T, Riu A, Fischer L, Will H, Sterneck M. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. HEPATOLOGY 2001;34:385-394.
19. Nassal M, Junker-Niepmann M, Schaller H. Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell 1990;63:1357-1363.
20. Xu Z, Jensen G, Yen TS. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 1997;71:7387-7392.
21. Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A 1991;88:1059-1063.
22. Sterneck M, Kalinina T, Gunther S, Fischer L, Santantonio T, Greten H, Will H. Functional analysis of HBV genomes from patients with fulminant hepatitis. HEPATOLOGY 1998;28:1390-1397.
23. Lenhoff RJ, Summers J. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol 1994;68:4565-4571.
24. Ghendon Y. WHO strategy for the global elimination of new cases of hepatitis B. Vaccine 1990;8(Suppl):S129-S133.
25. Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J Infect Dis 1997;175:511-523.
26. Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K. Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. EMBO J 1998;17:6839-6845.
27. Clayton RF, Owsianka A, Patel AH. Evidence for structural differences in the S domain of L in comparison with S protein of hepatitis B virus. J Gen Virol 2001;82:1533-1541.
28. Loffler-Mary H, Dumortier J, Klentsch-Zimmer C, Prange R. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins. Virology 2000;270:358-367.
29. Prange R, Werr M, Loffler-Mary H. Chaperones involved in hepatitis B virus morphogenesis. Biol Chem 1999;380:305-314.
30. Lambert C, Prange R. Chaperone action in the posttranslational topological reorientation of the hepatitis B virus large envelope protein: Implications for translocational regulation. Proc Natl Acad Sci U S A 2003;36:313A.
31. Gurer C, Cimarelli A, Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol 2002;76:4666-4670.
32. Kamili S, Araujo A, Yokosawa J, Locarnini S, Trautwein C, Spelbring J, Khudyakov Y, et al. Experimental infection of chimpanzees with genetically engineered S-gene mutants of hepatitis B virus. HEPATOLOGY 2002;36(Suppl 4):313A.